Skip to nav Skip to content

News Releases and Statements

Facebook Twitter LinkedIn Email

IDSA Dismissed from Lawsuit Judge Rules Lawsuit Against IDSA Baseless

In legal rulings issued on Sept. 1 and Sept. 20, a federal judge in Texas dismissed all claims a group of Lyme disease patients had brought against the Infectious Diseases Society of America.  

Drug-resistant Infections Led to $1.9 Billion in Health Care Costs, More Than 10,000 Deaths Among Older Adults in One Year

Infections caused by bacteria resistant to multiple antibiotics led to $1.9 billion in health care costs, more than 400,000 days in the hospital and more than 10,000 deaths among older adults across the U.S. in 2017, according to a new study published today in Clinical Infectious Diseases.

IDSA Awarded Second CDC Grant for Continued COVID-19 Support for Health Care Workers

IDSA and the Centers for Disease Control and Prevention have announced they will continue their collaborative effort to support frontline health care professionals caring for patients with COVID-19.

Statement on Resignation of NIH Director Francis Collins

Dr. Collins has provided a steady, scientific voice throughout the COVID-19 pandemic. Under his leadership, NIH was instrumental in researching, developing and communicating about lifesaving COVID-19 vaccines and treatments. 

Clinical Considerations in Caring for Individuals Recently Returning and Evacuated from Afghanistan to the United States

IDSA, PIDS and SHEA recommend, in collaboration with the U.S. Centers for Disease Control and Prevention, that clinicians caring for these evacuees consider the varied presentations of medical conditions, including infectious diseases.

New Journal of Infectious Diseases Supplement Spotlights Vaccination Triumphs and Remaining Challenges

A special collection of new articles published in The Journal of Infectious Diseases highlights the great benefits to human health achieved by the development and use of vaccines.

IDSA Provides Comments to the National Quality Forum Patient Safety Standing Committee on the Severe Sepsis and Septic Shock: Early Management Bundle

IDSA has stated its opposition to the National Quality Forum’s re-endorsement of the Severe Sepsis and Septic Shock: Early Management Bundle (SEP-1) quality measure, as the Society has major concerns with the SEP-1 measure as it is currently specified.

Study Shows Black Women with HIV Had Highest Rates of Premature Mortality Between 1998-2018

Researchers at Vanderbilt University Medical Center found that despite improvements in mortality rates among people with HIV over 20 years, women had a higher risk of mortality than men, and Black women had the highest years of potential life lost, according to a study presented at IDWeek.

IDSA Recognizes Leading Infectious Diseases Experts

The Infectious Diseases Society of America is honoring 12 exemplary leaders in the field at IDWeek 2021. IDSA is pleased to recognize the following members for excellence in the field of infectious diseases:

Common Cold Virus Continued to Circulate in the midst of the SARS-CoV-2 Pandemic

New research shows that in 2020-2021, while the circulation of influenza, RSV, and other respiratory viruses declined sharply, rhinovirus/enterovirus – which causes the common cold – persisted and continued to circulate among children, according to a study presented at IDWeek.

National Ambulatory Antibiotic Stewardship Program Offers Hope in Fight Against Antimicrobial Resistance

A new program to ensure antibiotics are used properly, funded by the Agency for Healthcare Research and Quality (AHRQ), was associated with declines in antibiotic prescribing in ambulatory clinics even in the face of COVID-19 related disruptions, according to results presented at IDWeek.

Molecular Imaging of Bacterial Infections Awarded Grand Prize at 2021 IDea Incubator Competition to Support Innovation for Improving Infectious Diseases Care

IDSA Foundation, in collaboration with JLABS, recently awarded more than $17,000 in funding through the 2021 IDea Incubator competition to three finalists for their promising innovations aimed at advancing the field of infectious diseases.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.